Search
Now showing items 1-10 of 13
Out of range laboratory values: a major reason for exclusion from a phase 1 HIV vaccine clinical trial
(University of Nairobi, 2006)
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Infection with Trichomonas vaginalis increases the risk for HIV-1 acquisition: A prospective study
(University of Nairobi, 2006)
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
(University of Nairobi, 2006)
Safety profile of DNA and MVA HIV preventive vaccines
(University of Nairobi, 2004)
Development of national guidelines for research and development of HIV/AIDS vaccines: The Kenyan experience
(University of Nairobi, 2006)